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Abstract
Background: Atrial fibrillation (AF) is a frequent and serious complication of coronary artery bypass graft (CABG) surgery.
Methods: We undertook a retrospective review of the records of patients undergoing CABG at Imam Ali Hospital between February 1, 
2003 and February 1, 2006. The patients were divided in two groups, ie, Group A (AF) and Group B (no AF). The association between 
the occurrence of AF following CABG and other variables was compared with respect to continuous or categorical variables by t-test 
and χ2-test.
Results: Multivariate logistic regression analysis of potentially predictive factors in univariate analysis showed that opium use, type of 
operation, and crossclamp time were predictors of AF following CABG.
Conclusion: This study identifies some new predictors of postoperative AF, control of which could lead to a lower incidence of AF and 
reduced morbidity, mortality, and resource utilization for patients undergoing cardiac surgery.
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Introduction
Atrial  fibrillation  (AF)  occurs  in  approximately 
25%–40%  of  patients  following  coronary  artery 
bypass grafting (CABG), and increases the risk of 
an adverse outcome, as well as increasing   hospital 
costs and health care resource consumption.1 AF is 
a  common  and  serious  cardiac  complication  post 
surgery. This arrhythmia originates in the atria, and 
instead of the impulse traveling in an orderly fashion, 
both the atria quiver at the same time.2 AF was once 
thought to be harmless, but is now recognized as a 
dangerous postoperative condition.2 AF is common in 
patients who require heart surgery for mitral valve, 
aortic valve, and/or coronary artery disease. AF con-
tributes significantly to mortality and morbidity, par-
ticularly in the elderly and in intensive care patients.3 
AF is a diverse arrhythmia which is clinically divided 
into three subtypes, ie, paroxysmal, persistent, and 
  permanent.4 Patients in whom sinus rhythm cannot 
be sustained after cardioversion are deemed to have 
  permanent AF.5 Surgeons require strategies to reduce 
the  incidence  of AF  following  CABG,  reduce  the 
associated hospital costs, and optimize the outcome 
of surgery.
Wolfe  et al  demonstrated that  postoperative AF 
increases mortality and morbidity following CABG.5 
Creswell et al6 investigated the relationship between 
postoperative  outcome  and  postoperative  atrial 
arrhythmia,7 and found that postoperative AF affects 
postoperative morbidity and mortality. Maisel et al 
investigated  occurrence  of  AF  following  CABG 
and showed that AF leads to longer intensive care 
and ward stays and more use of hospital resources.8 
Other retrospective and prospective studies have also 
confirmed a relationship between postoperative AF 
and adverse outcomes.9,10 This study details the results 
of our investigation of postoperative AF using novel 
variables to identify predictors of postoperative AF in 
CABG patients at Imam Ali Hospital.
Methods and Materials
Between February 1, 2003 and February 1, 2006, 700 
patients were entered in this retrospective study and 
data on approximately 31 variables were collected 
by two dedicated intensive care unit nurses. Thirty 
patients were excluded for having a history of AF 
before their operation, incomplete or missing data, 
CABG with valvular surgery, death in the operating 
room or during the early hours of intensive care stay, 
or offpump CABG.
The  variables  analyzed  included  preoperative, 
intraoperative, and postoperative parameters, out-
comes, and complications. Risk factors and relevant 
clinical data were investigated for their relationship 
with the onset of new postoperative AF. The preopera-
tive variables included in the study were age, gender, 
body  mass  index,  body  weight,  ejection  fraction, 
tobacco use, opium use, systemic hypertension, diabetes 
mellitus, peripheral vascular disease, cerebrovascular 
disease, preoperative hematocrit, chronic obstructive 
pulmonary disease, preoperative renal insufficiency, 
congestive  heart  failure,  preoperative  digoxin  use, 
Aspirin  using,  pO2  on  air,  pCO2  on  air,  preopera-
tive  beta-blocker  use,  preoperative  nipride  use, 
left  main  stem  disease,  preoperative  heparin  use, 
and  hyperlipidemia.  Intraoperative  variables  were 
crossclamp time, pump time, left internal mammary 
artery use, type of operation, need for inotropic support, 
and number of grafts. Postoperative variables were 
congestive  heart  failure,  postoperative  myocardial 
infarction, infection, pulmonary complications, renal 
insufficiency, postoperative infection, cerebrovascular 
accident,  gastrointestinal  complications,  emergency 
operation, postoperative bleeding, intra-aortic balloon 
pump  use,  reintubation,  elective  surgery,  inotropic 
drug use, duration of hospital stay, and death.
Definition of Terms
Hypertensive patients were defined as those receiving 
antihypertensive  treatment.  Ejection  fraction  was 
assessed  by  catheterization  or  echocardiography, 
and  cerebrovascular  disease  included  those  with  a 
history of stroke, transient ischemic attack, or both. 
Peripheral vascular disease was defined as a history 
of  intermittent  claudication  or  vascular  surgery. 
Preoperative renal insufficiency was determined as 
serum creatinine .2 mg/dL. Surgery was considered 
to  be  elective  if  the  patient  was  admitted  to  the 
Department of Cardiac Surgery electively on the day 
preceding  the  operation.  Urgent  operations  were 
defined as surgery performed on the day of referral or 
on the following day.
The operative technique was similar in all patients. 
After anesthesia, a median sternotomy was performed, 
followed  by  routine  aortic  and  atrial  cannulation. 
Cardiopulmonary  bypass  was  carried  out  using Prediction of AF after CABg
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membrane  oxygenation,  nonpulsatile  perfusion, 
and  moderate  systemic  hypothermia.  Myocardial 
protection  was  achieved  by  cold  hyperkalemic 
crystalloid  cardioplegia  and  topical  cooling  with 
iced slush and cold saline solution. Cardioplegia was 
administered in a retrograde and antegrade fashion 
in all patients and reinfusion was not used routinely 
during surgery. Coronary artery bypass grafting was 
performed using the left internal mammary artery and 
reversed saphenous vein in most instances.
Hospital death was defined as death occurring within 
30 days of surgery. Infection included any postoperative 
complication requiring antibiotic therapy. Pulmonary 
complications comprised all those leading to prolonged 
mechanical ventilation.   Intra-abdominal complications 
included only those requiring   operative intervention. 
Low cardiac output was defined as a need for inotropic 
support or an intra-aortic balloon pump.
statistical Analysis
Continuous and categorical variables between patients 
with postoperative AF (Group A) and those without 
AF (Group B) were compared by t-test and χ2 test, 
respectively.  Statistically  significant  variables  in 
the univariate analysis (P # 0.1) were selected and 
entered into a multiple logistic regression model. The 
sensitivity and specificity of variables predicting AF 
were obtained using a receiver-operating characteristic 
curve (Fig. 1). Patients with a hospital stay $12 days 
and those with a stay ,12 days were compared by t-test 
with respect to postoperative AF. A P value , 0.05 were 
considered to be statistically significant, and the odds 
ratio (OR) and 95% confidence interval (CI) for each 
significant variable in this model were calculated.
Results
In total 670 patients were included in this study. Of 
these, 69.5% were men and 30.5% were women, aged 
33–87 years, in whom 21.1% had diabetes, 38.9% had 
hypercholesterolemia, 35% had hypertriglyceridemia, 
6% had had a preoperative myocardial infarction, and 
4.7% had had a postoperative myocardial infarction. 
In  total,  49.3%  were  current  smokers,  14%  were 
opium addicts, 7% had chronic obstructive pulmonary 
disease, and 5.9% had congestive heart failure. Mean 
left ventricular ejection fraction was 53% ± 6%. Some 
7.4% had undergone emergency surgery, and 92.6% 
underwent surgery as elective patients; 13.9% had left 
main stem disease, 14.4% patients had one graft, 27% 
had two grafts, 19.8% had three grafts, 37.2% had 
four grafts, and 1.6% had five grafts. The left internal 
mammary was used in 96.1% of patients. Eighty-one 
(11%) patients needed an intra-aortic balloon pump 
for 24 hours and 19.6% needed inotropic support. 
Other major immediate postoperative complications 
included  respiratory  failure  (4%),  renal  failure 
(2.3%), cerebrovascular accident (2.08%), infection 
(2%),  bleeding  (6.9%),  and  reintubation  (4.1%). 
Twenty patients (2.9%) died as a result of infection, 
multiorgan  failure,  or  cerebrovascular  accident. 
Hospital  stay  was  #12  days  in  60.6%  of  patients 
and .12 days in 39.4%.
Preoperative variables and patient demographic fac-
tors are shown in Table 1. There was no significant dif-
ference in univariate analysis for weight, age, left main 
stem disease, preoperative hematocrit, pO2 on air, dia-
betes, chronic obstructive pulmonary disease, smok-
ing, congestive heart failure, preoperative nipride use, 
and preoperative creatinine .2 mg/dL between Group 
A and Group B. The majority of the patients were male 
(68.77%), with a mean age of 55.07 ± 9.1 years. The 
age range of the whole group was 33–87 years, and 
4.1% of male and 7.6% of female patients had AF. Two 
hundred and fifty patients had a hospital stay #12 days 
and 6.5% of them had AF, while 420 patients had a 
longer  hospital  stay,  of  whom  30  (7.1%)  had  AF. 
χ2 showed significant differences with respect to occur-
rence of AF between the two groups. The two groups 
of patients (stay $12 or ,12) were compared with 
respect to number of grafts and there was a significant 
difference, with more grafts in patients with a hospital 
stay $12 days (P = 0.006). In univariate analysis, pre-
operative hypertension and intravenous nitroglycerin 
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Figure 1. receiver-operating characteristic curve.
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use were not significant markers of AF, but preopera-
tive nipride use did predict AF (Table 1).
The age and gender distribution of the patients is 
shown in Table 1. There was no significant difference 
with respect to gender (P = 0.54). Univariate analysis 
identified  intraoperative  variables  which  had  a 
significant  association  with  AF  following  CABG. 
The  most  significant  risk  factors  were  crossclamp 
time  and  inotropic  drug  use  (P  ,  0.05,  Table  2). 
Some  postoperative  variables  showed  a  significant 
association with AF following CABG (Table 3). These 
factors included death, reintubation, and postoperative 
bleeding.  Other  important  factors  in  univariate 
analysis were postoperative myocardial infarction and 
use of an intra-aortic balloon pump. Eight variables 
Table 1. Preoperative predictors of postoperative atrial fibrillation.
Variable AF no AF P value
ejection fraction 43 ± 0.5 54 ± 0.4 0.100
Weight 72.31 ± 11.4 68.84 ± 13.7 0.006
Preoperative digoxin use 5% 13% 0.040
Preoperative beta-blocker use 33% 36% nS
Age 58.52 ± 9.4 54.81 ± 9.07 0.011
Preoperative hematocrit 39.04 ± 5.2 41.4 ± 5.6 0.004
pO2 on air 77.01 ± 18.3 90.03 ± 24.3 0.000
pCO2 on air 33.47 ± 6.2 34 ± 1.1 nS
Left main disease 8.8% 3.1% 0.010
Preoperative serum creatinine 8% 2.8% 0.000
Diabetes 51.8% 25.4% 0.026
hypercholesterolemia 46.3% 38.4% 0.160
hypertriglyceridemia 41.4% 35.5% 0.077
Smoking 50% 30% 0.027
Opium use 12.1% 14.4% 0.900
Chronic obstructive pulmonary disease 8.3% 4.5% 0.000
Congestive heart failure 7.9% 2.8% 0.000
Aspirin use 91% 93% 0.450
Preoperative nipride use 26.8% 31% 0.040
Preoperative heparin use 12.1% 4.4% 0.060
notes: results are expressed as mean ± standard deviation. Differences were considered significant at P , 0.05. 
Abbreviations: AF, atrial fibrillation; NS, not statistically significant.
Table 2. Intraoperative predictors of postoperative atrial 
fibrillation.
Variable AF no AF P value
no LIMA use 4.9% 0% 0.06
Clamp time 87 ± 12 67 ± 15 0.04
Pump time 136 ± 12 111 ± 12 0.05
Inotropic support 12.5% 4.5% 0.04
notes: results are expressed as means ± SD. Differences were considered 
significant at P , 0.05. 
Abbreviations: AF, atrial fibrillation; LIMA, left internal mammary artery.
were predictors of AF in a logistic regression model 
(Table 4). The most important variables among the 
preoperative patient characteristics were opium use, 
age, chronic obstructive pulmonary disease, congestive 
heart failure, and pO2 on air, which predicted AF with 
ORs of 0.37, 1.05, 67, 3.95, and 15.8, respectively.
Intraoperative variables associated with AF included 
a longer crossclamp time (OR 5.4) and intra-aortic bal-
loon pump use (OR 1.0). The need for inotropic agents 
in the postoperative period and in the intensive care unit 
was another predictor of AF (OR 5.2). Stroke, defined 
as regional neurological deficit, such as hemiplegia or 
paraplegia, or diffuse deficit-like coma, within 30 days 
after surgery, was not an independent predictor of AF 
(P . 0.05). However, postoperative AF was related to 
increased morbidity and other serious events, and the 
rate of these events was twice as high as in those in 
whom AF had not developed.
AF occurred in 100 patients (15%) and there were 
six cases of cerebrovascular accident (6% and 1.4%) 
between  the  AF  (n  =  100)  and  non-AF  (n  =  570) 
patients, respectively (P , 0.05). However, in logistic 
regression,  stroke  did  not  predict  postoperative  AF. 
Requirements  for  inotropic  support  and  reintubation 
were different between patients with postoperative AF 
versus those with no AF (P , 0.05). Median duration of Prediction of AF after CABg
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stay in intensive care was 96 ± 4 hours for patients with 
AF, compared with 48 ± 8 hours for patients with no 
AF. Postoperative mortality at 30 days was significantly 
higher in patients with postoperative AF (5.6%) com-
pared with those without AF (1.6%, P , 0.05) Fifty 
percent of the patients were in New York Heart Asso-
ciation  functional  class  I,  33%  were  in  functional 
class II, 11% were in functional class III, and 6% were 
in functional class IV (Table 5). Patients in functional 
class III showed differences with respect to AF; 50% of 
those with AF were in functional class III, while 26% of 
those without AF were in functional class III (Table 5). 
The number of grafts had no effect on the incidence 
of AF (Table 6). The incidence of AF in patients with 
crossclamp time #60 minutes and .60 minutes was 
5%  and  30%,  respectively.  Patients  with  a  pump 
time $100 minutes showed a higher incidence of AF 
(P , 0.05). Sensitivity and specificity of gender for 
predicting AF was 78% and 70%, respectively, in a 
receiver-operating characteristic curve.
AF is a frequent complication of cardiac surgery. 
In this setting, AF is usually a transient arrhythmia, 
but cerebral embolism is a known complication of 
sustained AF in the postoperative setting. Thus, AF 
could play a role in stoke following cardiac surgery. 
In low-risk patients, AF can extend hospital stay by 
leading to early readmission, and often requires use 
of antiarrhythmic drugs with significant side effects.9 
In high-risk patients, a 10% decrease in cardiac output 
after onset of rapid AF can lead rapidly to increased 
morbidity due to the need for inotropic support and an 
intra-aortic balloon pump, and often requires imme-
diate cardioversion in an ill postoperative patient.10
AF  also  brings  up  the  issue  of  anticoagulation 
in  newly  postoperative  patients,  because  there  is  a 
reported three-fold increased incidence of peripheral 
emboli and stroke after the onset of AF.11 AF has a low 
incidence in the general population, which increases 
with advancing age, as noted by Aranki et al12 who 
reported an incidence of 0.4% for individuals younger 
than 70 years which increased to 2%–4% in those older 
than 70 years.12 The incidence of AF in   hospitalized 
Table 3. Postoperative predictors of postoperative atrial 
fibrillation.
Variable AF no AF P value
IABP use 8% 4% 0.00
respiratory  
complication
7.3% 3.7% 0.00
renal complication 5.1% 2.1% 0.10
Postoperative  
infection
2.4% 1.9% 0.70
gastrointestinal  
complication
4.8% 1.3% 0.80
Postoperative  
bleeding
9.1% 5.9% 0.00
Cerebrovascular  
accident
2.4% 1.6% 0.50
emergency operation 10% 6.5% 0.06
Duration of  
hospital stay
4–12 days 3–9 days
Postoperative MI 7.8% 4.1% 0.04
elective operation 86% 93.5% 0.50
reintubation 6.7% 2.4% 0.00
Death 5.6% 1.6% 0.00
notes: results are expressed as mean ± standard deviation. Differences 
were considered significant at P , 0.05. 
Abbreviations: AF,  atrial  fibrillation;  IABP,  intra-aortic  balloon  pump;   
MI, myocardial infarction.
Table 4. Multivariate regression model for atrial fibrillation.
Variable B se Wald DF sig exp (B) 95% cI
Lower Upper
Opium use 0.99 0.430 5.30 1 0.020 0.37 0.937 1.003
Age 0.05 0.023 6.63 1 0.010 1.05 1.01 1.1
COPD 1.37 0.455 9.10 1 0.002 67 29.8 154.1
Clamp time 1.60 0.400 15.30 1 0.020 5.40 2.29 12.9
ChF 4.21 0.420 100 1 0.000 3.95 0.783 8.21
pO2 on air 2.76 0.900 9.40 1 0.002 15.80 2.72 92.1
IABP use 3.50 0.510 49.40 1 0.000 1 36.1 13.27
Inotropic support 1.66 0.620 6.90 1 0.008 5.20 1.53 13.04
Constant 4.73 2.070 5.10 1 0.023 0.009 3.1 219.3
Abbreviations: CI, confidence interval; SE, standard error of the mean; DF, degrees of freedom; COPD, chronic obstructive pulmonary disease; CHF, 
congestive heart failure; IABP, intra-aortic balloon pump.Sabzi et al
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patients was reported to be 24% by Goldman.13 Smith 
et al14 and Stephenson et al15 reported an AF incidence 
rate of 10% after cardiac valve surgery and open heart 
surgery. The highest incidence reported was 65% by 
Mathew et al16 but the incidence of AF after coronary 
artery bypass graft surgery is much lower, ranging 
from 3.3% to 30%.16,17 The risk of AF in some patients 
is high. For example, Cox et al18 found that the most 
important risk factor for postoperative AF was chronic 
obstructive pulmonary disease and hypertension.18 Our 
study found an incidence of 15% for postoperative AF, 
which was similar to the findings of some studies, but 
different to others, which could be explained by differ-
ences in the type of operative procedures included. We 
excluded valvular surgery and combined CABG and 
valvular surgery because of the likelihood of a lower 
incidence of AF, and valvular surgery cases constitute 
20% of our patients.
Chen et al and Fuller et al in two separate studies 
suggested that postoperative AF was a benign rhythm 
disturbance  and  self-limiting,  and  does  not  increase 
the incidence of stroke or embolism. However, with 
the accumulation of more and more data from multiple 
studies, it has become evident that postoperative AF 
is an important risk factor for a serious postoperative 
outcome.19,20  The  etiology  of  AF  following  cardiac 
surgery may be multifactorial, and includes intraoperative 
handling of the right atrium,21 suture of the cannulation 
site,21  suture  at  the  site  of  a  retrograde  cannula,21  a 
large hematoma in the atrial wall,21 venting of the right 
superior  pulmonary  vein,22  traumatic  laceration  of 
atrial tissue,22 inadequate atrial tissue preservation by 
cardioplegia,23 inadequate use of iced slush/cooling of 
the atria,19,24 beta-blocker withdrawal,25 hypothyroidism, 
withdrawal of thyroid hormone replacement therapy in 
the preoperative period,26 pericarditis, and many other 
factors.27,28 Suture line, hematoma, and other traumatic 
causes of AF lead to a lack of uniformity in the atrial 
refractory period, and dispersion of refractoriness is a 
mechanism underlying the vulnerability of atrial tissue 
to development of AF. Hypothyroidism reduces cardiac 
contractility and lead to increase peripheral resistance, 
capillary permeability, and AF. In other hand, thyroid 
replacement  therapy  improves  cardiac  diastolic 
function  and  systemic  vascular  resistance,  and  may 
induce myocardial ischemia and cardiac arrhythmia. 
Therefore, experts have not reached a consensus about 
the need to replace thyroid hormone in patients with 
coronary artery disease.26
One of the most important risk factors for postopera-
tive AF in our study was chronic obstructive pulmonary 
disease (OR 67), as reported by Holford et al.29 Patients 
with chronic obstructive pulmonary disease, asthma, 
acute  respiratory  distress  syndrome,  and  other  risk 
factors for respiratory failure have a high incidence 
of AF. Patients with these lung diseases may have an 
intrapulmonary shunt, ventilation-perfusion mismatch 
associated by atelectasis, reduced vital capacity, and 
other abnormal ventilatory mechanics following cardiac 
surgery which aggravate arterial hypoxia, leading to 
hypoxia of the atrial tissue and AF. Atrial tissue is more 
vulnerable to hypoxia than myocardium. The OR of 
chronic obstructive pulmonary disease in our study in 
logistic regression was 67. It is probable that hypoxia 
leads to AF, which leads to low cardiac output, and this 
vicious cycle leads to further deterioration of hypoxia 
and  fatal  events.  Creswell  et  al6  showed  that  these 
patients have more premature atrial contractions, which 
can predispose to AF. Our study did not investigate 
premature atrial contractions as a risk factor for AF, and 
this is a limitation of our study. In another retrospective 
study, Leitch et al30 confirmed the relationship between 
chronic obstructive pulmonary disease and AF. In the 
past,  the  preoperative  existence  of  congestive  heart 
failure was thought to increase the incidence of AF. 
Multiple  studies,  including  the  present  one,  show 
Table 5. relationship between new York heart   Association 
functional class and postoperative atrial fibrillation.
Functional class AF no AF P value
I 50% 63% 0.09
II 33% 26% 0.8
III 11% 7.6% 0.05
IV 6% 3.4% 0.9
note: Differences were considered significant at P , 0.05.
Abbreviation: AF, atrial fibrillation.
Table 6. relationship between number of grafts and post-
operative atrial fibrillation.
Grafts (n) AF no AF P value
One 6.8% (4/58) 93.1% (54/58) .0.05
Two 2.5% (4/160) 99.5% (156/160) .0.05
Three 0.5% (16/320) 95% (3.4/32) .0.05
Four 7.9% (17/151) 92.1% (139/151) .0.05
note: Differences were considered significant at P , 0.05.
Abbreviation: AF, atrial fibrillation.Prediction of AF after CABg
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the effectiveness of using digoxin in this scenario,25 
and Roffman has suggested that the combination of 
beta-blockers and digoxin is effective in reducing the 
incidence  of AF  postoperatively  in  these  patients.36 
Univariate analysis showed that preoperative digoxin 
use, but not propranolol, reduced the incidence of AF, 
but the reduction was not significant in multivariate 
analysis.
Our study showed that the existence of preopera-
tive congestive heart failure is a risk factor for genesis 
of postoperative AF (OR 2.5). We believe that digoxin 
sensitizes the atrial tissue, and that congestive heart 
failure necessitates its use in the preoperative period. 
On the other hand, the presence of congestive heart 
failure,  combined  with  high-dose  inotropic  support 
(OR 5.2) and intra-aortic balloon pump use (OR 1.0) 
lead to tissue hypoxia, acidosis, and arrhythmia, neces-
sitating antiarrhythmic use and also sensitizing atrial 
tissue to AF (Table 3). This is in contrast with the find-
ings of a study by Hashimoto et al.32 We believe that 
use of digoxin and propranolol can reduce the inci-
dence of AF, but if these drugs are using to treat con-
gestive heart failure or a combination of congestive 
heart failure and AF, they actually increase the inci-
dence of AF by the above mechanism. In univariate 
analysis, preoperative hypertension was not as signifi-
cant a marker of AF as intravenous nitroglycerin use, 
but preoperative nipride use was a predictor of AF. We 
conclude that severe hypertension controlled only by 
a combination of drugs predicts postoperative AF.
Rubin showed that the use of propranolol in the 
preoperative period decreased the rate of postoperative 
AF.33 However, preoperative use of a beta-blocker in 
our study was not associated with a decreased incidence 
of AF. Leitch et al found a similar relationship between 
preoperative beta-blocker use and AF.30 Mathew et al21 
found an association between intraoperative variables, 
such as venting of the left ventricle via the right supe-
rior pulmonary vein, or mitral valve repair, and AF.21 
This  issue  might  be  related  to  local  trauma  (suture 
line) at the site of vent insertion or a combination of 
venting  and  high  left  ventricular    diastolic    pressure 
or  left  ventricular  dysfunction  and  use  of  digoxin 
or  antiarrhythmic  drugs,  acidosis,  and  other  factors 
predisposing to development of AF. Another intraoper-
ative risk factor for positive AF is dissection, and local 
trauma to the interatrial groove, and has been shown 
for mitral valve repair or replacement.21–24
Two  intraoperative  risk  factors  for  development 
of postoperative AF are pump time and aortic cross 
clamp time, as shown by Mathew.21 Some types of 
surgery, such as combined CABG and valve surgery 
require  longer  cardiopulmonary  bypass  and  cross-
clamp times, and these may be confounding factors 
in the genesis of AF. We excluded combined surgery 
from our study, which may have led to the short cross 
clamp and pump times and the low incidence of AF 
in our study. We found that a long cross clamp time 
significantly  increases  the  likelihood  of  developing 
AF after CABG. Local hypothermia, as reported by 
Almassi et al22 was found to reduce the risk of AF. 
Chen et al11 showed that lack of local hypothermia 
combined with continuous electrical activity during 
arrest increased the risk of AF.19 After infusion of the 
first dose of cardioplegia, atrial tissue cooled only to 
20 °C (in contrast with the myocardium which rap-
idly cooled down to 6 °C) with continuous electrical 
activity, and anaerobic metabolism of atrial tissue in 
the arrested heart led to AF. We routinely use multiple 
antegrade and retrograde doses of cardioplegia and 
iced slush, which may have led to our low rate of AF.
In our study, multivariate regression analysis implied 
that  use  of  high-dose  inotropic  agents  increased  the 
incidence of postoperative AF (OR 5.2). The need for 
postoperative inotropic support is associated with sev-
eral risk factors, including low ejection fraction, high 
left ventricular diastolic pressure,34 inadequate preserva-
tion of myocardium by cardioplegia, lack of retrograde 
cardioplegia,35 and incomplete revascularization follow-
ing beating heart surgery in patients with multivessel 
disease.36,37  Some  surgeons  use  inotropic  agents  rou-
tinely during weaning from cardiopulmonary bypass, 
which makes it difficult to identify factors contributing to 
development of AF. We routinely avoid using inotropic 
support during weaning from cardiopulmonary bypass, 
even in patients with low ejection fraction, so this prob-
lem could not have confounded our findings regarding 
an association between inotropic agents and AF, and our 
findings are similar to those reported elsewhere.38
Our study showed that some postoperative events, 
including congestive heart failure, chronic obstructive 
pulmonary disease, opium use, and low pO2 levels on 
air were associated with AF (ORs 3.95, 67, 0.37, and 
15.8, respectively). We believe that respiratory failure, 
ie,  congestive  heart  failure  and  chronic  obstructive 
pulmonary disease, contributed to development of AF Sabzi et al
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via a hypoxic mechanism. Patients with AF had had 
other morbid events in the intensive care unit, such as 
hemodynamic instability, atelectasis, hypoxia, longer 
ventilation time, and longer duration of stay. All of the 
these events can be risk factors for AF, and it is dif-
ficult to determine whether the presence of respiratory 
failure contributed to AF, or whether AF caused respi-
ratory failure as a result of congestive heart failure.
Opium  use  was  not  statistically  significant  in 
univariate analysis, but was significant in multivariate 
analysis, with a small OR of 0.37. Opium is available 
in most countries, and is distributed and consumed 
illegally. Unlike pure opiates, such as morphine and 
heroin, opium is a mixture of different substances 
with different effects. The most important extracts of 
opium are morphine and codeine, which are potent 
analgesics. Other alkaloids, such as papaverine and 
noscapine, as well as inert substances and various 
adulterants,  are  among  the  complex  constituents 
of  opium  consumed  by  drug  abusers.  Different 
substances added to opiates may produce a variety 
of  effects.39  Moreover,  patients  using  opium  are 
invariably cigarette smokers as well and have chronic 
obstructive  pulmonary  disease,  which  could  have 
introduced some bias into the interpretation of our 
findings.
Stroke is a well recognized complication of cardiac 
surgery.39 Some strokes occur as a result of intraop-
erative events, and become evident during recovery 
from anesthesia. These strokes may result from air or 
atheromatous emboli.40 Other strokes occur later in the 
postoperative period after the patient has recovered 
neurologically intact from anesthesia,41 and despite 
improvement in surgical and anesthesia techniques, 
very little progress has been made in decreasing the 
incidence of postoperative stroke.
Emboli originating from the fibrillating left atrium 
in AF are a known cause of strokes in the surgical 
setting; the 15% incidence in our study is consistent 
with that reported by others.39–42 We found an important 
relationship between stroke and occurrence of AF in 
postoperative period. Three percent of our study patients 
developed both AF and post CABG stroke, with AF 
preceding the stroke. Postoperative stroke was over 4.2 
times more likely to occur if the patient had AF.
Sage and Van Uitert found that AF increased the 
risk of stroke, and that the risk was independent of any 
associated heart failure or coronary artery disease.40 
Taylor et al41 in a study of 500 patients, found a 6% 
rate of stroke in AF patients. In the Creswell et al 
study, this incidence was 3.3%.6 None of these stud-
ies  reported  the  temporal  relationship  between AF 
and stroke nor the duration of AF, and this is also a 
limitation of our study. As a result of our experience, 
we use a protocol to decrease the incidence of post-
operative AF that includes routine intraoperative use 
of amiodarone, with consideration of anticoagulants 
if AF does not abate within 12 hours. These strate-
gies lead to a lower incidence of AF and reduced mor-
bidity, mortality, and resource utilization in patients 
undergoing cardiac surgery.
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